Quantitative Urine Metabolomics of Gitelman Syndrome Patients with Biallelic Pathogenic SLC12A3 Mutations and Healthy Controls

Published: 16 October 2026| Version 1 | DOI: 10.17632/6y354wrx42.1
Contributor:
Jian Han

Description

Quantitative urine metabolomics dataset of 22 human samples from two groups: healthy controls (HC, WET 1–WET 11) and Gitelman syndrome patients with biallelic pathogenic SLC12A3 mutations (HOM, HOM 1–HOM 11). The study compares urine metabolic profiles to investigate mechanisms related to electrolyte imbalance, energy metabolism, oxidative stress, and renal tubular dysfunction.

Files

Categories

Metabolomics, Human

Licence